Creative Planning
CSCI

Creative Planning’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

Creative Planning’s Portfolio CSCI Stock Details CSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-100
Closed -$30K – 2125
2019
Q2 		$30K Buy
+100
New +$35.3K ﹤0.01% 1859
2017
Q2 		– Sell
-20
Closed -$6K – 4866
2017
Q1 		$6K Hold
20
– – ﹤0.01% 3896
2016
Q4 		$7K Sell
20
-30
-60% -$11.2K ﹤0.01% 3794
2016
Q3 		$17K Buy
+50
New +$17.5K ﹤0.01% 3178
2016
Q2 		– Hold
0
– – – 4553
2016
Q1 		– Sell
-9
Closed -$2.97K – 4564
2015
Q4 		$4K Sell
9
-11
-55% -$6.91K ﹤0.01% 3813
2015
Q3 		$18K Buy
20
+10
+100% +$14.6K ﹤0.01% 2820
2015
Q2 		$28K Buy
+10
New +$42.1K ﹤0.01% 1056
2013
Q4 		– Hold
0
– -$1K – 3495
2013
Q3 		– Hold
0
– – – 3127
2013
Q2 		– Hold
0
– – – 2854

Other funds holding CSCI

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return

Creative Planning's CSCI Position: Q3 2019 in Review

Creative Planning sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q3 2019, closing a stake of 100 shares — an estimated $30K sold.

Creative Planning first reported a position in CSCI in Q2 2015 and held it in 7 quarters. The position peaked at $30K in Q2 2019. 26 funds tracked by Wall St. Rank hold CSCI as of Q3 2019.

  • Creative Planning reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Creative Planning sold 100 COSCIENS Biopharma Inc. Common Stock shares in Q3 2019, an estimated $30K.
  • Creative Planning first reported a position in COSCIENS Biopharma Inc. Common Stock in Q2 2015 and held it in 7 quarters.
  • Creative Planning's COSCIENS Biopharma Inc. Common Stock position peaked at $30K in Q2 2019.
  • 26 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q3 2019.

Based on Creative Planning's 13F filing for Q3 2019, filed 1 Nov 2019.